KLDO vs. HTGMQ, GNCA, VIVE, ONCSQ, AHPI, ATNFW, SXTPW, DRTSW, APLMW, and ARTLW
Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include HTG Molecular Diagnostics (HTGMQ), Genocea Biosciences (GNCA), Viveve Medical (VIVE), OncoSec Medical (ONCSQ), Allied Healthcare Products (AHPI), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
Kaleido Biosciences (NASDAQ:KLDO) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.
In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.
Kaleido Biosciences received 54 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.
Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 2.97, meaning that its stock price is 197% more volatile than the S&P 500.
HTG Molecular Diagnostics has higher revenue and earnings than Kaleido Biosciences.
81.6% of Kaleido Biosciences shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Kaleido Biosciences and HTG Molecular Diagnostics tied by winning 3 of the 6 factors compared between the two stocks.
Get Kaleido Biosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kaleido Biosciences Competitors List
Related Companies and Tools
